RTX vs UNH: Which Is the Better Buy?
Side-by-side comparison of RTX Corporation and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
RTX Corporation · Industrials
$185.60
-25.2% upside to fair value
Grade D
VS
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
UNH trades at a lower forward P/E
(27.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
RTX |
UNH |
| Current Price |
$185.60 |
$423.38 |
| Fair Value Estimate |
$138.81 |
$613.90 |
| Upside to Fair Value |
-25.2%
|
+45.0%
|
| Market Cap |
$249.9B |
$384.5B |
| Forward P/E |
34.3x
|
27.2x
|
| EV / EBITDA |
18.3x
|
13.8x
|
| Price / Sales |
2.8x
|
0.8x
|
| Price / FCF |
29.9x
|
19.6x
|
| Revenue Growth YoY |
+8.7%
|
+0.4%
|
| Gross Margin |
20.2%
|
18.8%
|
| Operating Margin |
10.9%
|
4.2%
|
| Return on Equity |
11.2%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.34%
|
5.12%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
RTX Corporation is a leading aerospace and defense company with a strong competitive moat driven by scale and an installed base in commercial aerospace via Pratt & Whitney and Collins Aerospace, and defense through Raytheon. The company benefits from a large multi-year backlog of approximately $270 billion supporting steady cash flow and mid-single-digit organic growth. Despite solid revenue grow…
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
| Metric |
RTX |
UNH |
| Zone Low |
$104.11 |
$460.42 |
| Zone High |
$117.99 |
$521.81 |
| In Buy Zone? |
No
|
Yes
|